Clinical Trial Update: Biomarkers to Enhance Early Schizophrenia Treatment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating biomarkers to improve early treatment of schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Northwell Health | Conditions: Schizophenia Disorder | Phase 4 | Status: RECRUITING